Replies to post #8083 on Tenax Therapeutics Inc (TENX)

[BioAddict]

That was my thought. The P2 was run by a Dr. that sits on the FDA Advisory board for Cardiac. P2 was stat sig with 37 patients. The indication is billions and billions per year in revenue.

I get it not a P3 but in my opinion P2 results in heart studies are much more predictive or actual results than in oncology.

Drug cost $180MM to get to this stage.

Drug already approved in other countries.

Just mind blowing.